Three-dimensional transesophageal echocardiography does not require contrast media, which may be particularly beneficial in patients with impaired renal function.
Endocardial left atrial appendage closure performed at high volume centers had the lowest in-hospital complications and 30-day readmissions, but with higher hospitalization costs.
This study adds to the understanding of the early complications associated with cardiovascular implantable electronic devices (CIEDs) and the institutional variability in the quality of CIED implantation.
A systematic review compared the safety and efficacy of prasugrel and ticagrelor in patients with ACS undergoing PCI.
Having atrial fibrillation, using home oxygen, having severe lung disease, or having a permanent pacemaker were predictive of lower health status after transcatheter mitral valve repair.
While wearable technology can provide substantial patient benefit, these devices carry significant privacy and security risks.
The safety risk of dermatoscope magnets in patients with cardiovascular implanted electronic devices was examined.
There is no difference between heparin and bivalirudin in terms of platelet aggregation or coagulation markers after pretreatment with ticagrelor in patients undergoing PPCI.
Same day hospital discharge has the potential increase the overall value of PCI care and save US hospitals approximately $577 million if implemented more consistently.
The Eluvia stent is designed to release paclitaxel for a 1-year time frame to prevent tissue regrowth that might otherwise block the stented artery.